Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Journal of Clinical Medicine|June 10, 2022
Learning to Care for the Older People: An Urgent Need in the Daily Practice of OncologistsGerardo RosatiExpert Opinion on Drug Safety|November 1, 2005
Elderly patients with advanced colorectal cancer: which therapy is the safest?Gerardo RosatiWorld Journal of Gastroenterology|March 25, 2010
Intensive or not surveillance of patients with colorectal cancer after curative resectionGerardo RosatiJournal of Chemotherapy (Florence, Italy)|December 29, 2020
Prolonged clinical response with regorafenib administered as second-line therapy in an elderly patient suffering from peritoneal carcinomatosis of colon cancerGerardo Rosati, Alessandro FéWorld Journal of Gastroenterology|March 20, 2008
Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancerGerardo Rosati, Domenico BilanciaTumori|October 14, 2006
Single-agent irinotecan as second-line weekly chemotherapy in elderly patients with advanced colorectal cancerGerardo Rosati, Stefano CordioWorld Journal of Gastroenterology|June 13, 2009
New perspectives in the treatment of advanced or metastatic gastric cancerGerardo Rosati, Domenica Ferrara, Luigi ManzioneRecenti Progressi in Medicina|June 27, 2022
[The TAILOR study establishes, in patients mCRC wt, the first line use of FOLFOX in combination with cetuximab]Alfredo Colombo, Gerardo Rosati, Concetta Maria PorrettoOncology|June 18, 2002
A phase II study of irinotecan alternated with a weekly schedule of high-dose leucovorin and 48-hour 5-fluorouracil infusion in patients with metastatic colorectal cancerGerardo Rosati, Antonio Rossi, Giorgio Reggiardo, et al.Oncology|May 22, 2003
Subcutaneous granulocyte-macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fluorouracil plus leucovorin regimen. A phase II study and review of the literatureAntonio Rossi, Gerardo Rosati, Diodoro Colarusso, et al.Pageof 9